首页 > 最新文献

Iranian journal of cancer prevention最新文献

英文 中文
Quality Assessment of the National Cancer Registry in Iran: Completeness and Validity 伊朗国家癌症登记的质量评估:完整性和有效性
Pub Date : 2016-12-10 DOI: 10.17795/IJCP-8479
G. Mohammadi, M. Akbari, Y. Mehrabi, A. Motlagh
Introduction: Cancer Registry is one of the important components of health information systems in developing countries. Continuous monitoring of data quality can have a crucial role in controlling cancers. This study aimed to assess the quality of cancer registry data in terms of completeness of coverage and validity. Methods: Data were collected from three main sources, including Pathology registry, Hospital and national death registries in five provinces in Iran during March 2008-March 2011. We used two source capture-recapture method for estimate of cancer registry coverage and measures of validity were percentage of death certificate only (DCO%), histological verified cases (MV%); cancer incidence in childhood based on sex and age group, percentage of cancer in the elderly (80 years or above) and mortality-to-incidence ratio (M:I).We compared them to international standards. Results: The overall completeness was estimated at 54.2% and 32.4% under reporting for stomach cancer in a period of three years (2008 - 2010). MV% and percentage of unknown primary site of the tumor were 68.7%, and 5% respectively. The mortality-to-incidence ratio for men and women was 37.6% and 28.2%, and percentage of cancer in the elderly was 10.9% in 2010 year. The age-specific rate in girls and boys in age groups of 5 - 9 and 10 - 14 years was lower than minimum of the recommended international standards. Conclusions: The results of this study showed data quality of cancer registry is relatively low in terms of the completeness and validity. Cancer registries should pay great attention to the quality of their data. In addition to technical measures in data processing, continuous evaluation of their quality in order to achieve the set goals is essential.
癌症登记是发展中国家卫生信息系统的重要组成部分之一。持续监测数据质量在控制癌症方面发挥着至关重要的作用。本研究旨在从覆盖的完整性和有效性方面评估癌症登记数据的质量。方法:从三个主要来源收集数据,包括2008年3月至2011年3月期间伊朗五个省的病理学登记处、医院和国家死亡登记处。我们使用两种来源捕获-再捕获方法来估计癌症登记覆盖率,有效性措施是仅死亡证明的百分比(DCO%),组织学验证的病例(MV%);按性别和年龄组划分的儿童癌症发病率、老年人(80岁或以上)癌症百分比和死亡率与发病率之比(M:I)。我们将它们与国际标准进行了比较。结果:在3年(2008 - 2010)期间,胃癌报告的总体完整性估计为54.2%和32.4%。原发部位未知的肿瘤发生率为68.7%,原发部位未知的肿瘤发生率为5%。2010年,男性和女性的死亡率与发病率之比分别为37.6%和28.2%,老年人癌症发病率为10.9%。在5至9岁和10至14岁年龄组中,女孩和男孩的具体年龄比率低于建议的最低国际标准。结论:本研究结果显示,癌症登记处的数据质量在完整性和有效性方面相对较低。癌症登记处应高度重视其数据的质量。除了数据处理中的技术措施外,为了实现既定目标,对其质量进行持续评估是必不可少的。
{"title":"Quality Assessment of the National Cancer Registry in Iran: Completeness and Validity","authors":"G. Mohammadi, M. Akbari, Y. Mehrabi, A. Motlagh","doi":"10.17795/IJCP-8479","DOIUrl":"https://doi.org/10.17795/IJCP-8479","url":null,"abstract":"Introduction: Cancer Registry is one of the important components of health information systems in developing countries. Continuous monitoring of data quality can have a crucial role in controlling cancers. This study aimed to assess the quality of cancer registry data in terms of completeness of coverage and validity. Methods: Data were collected from three main sources, including Pathology registry, Hospital and national death registries in five provinces in Iran during March 2008-March 2011. We used two source capture-recapture method for estimate of cancer registry coverage and measures of validity were percentage of death certificate only (DCO%), histological verified cases (MV%); cancer incidence in childhood based on sex and age group, percentage of cancer in the elderly (80 years or above) and mortality-to-incidence ratio (M:I).We compared them to international standards. Results: The overall completeness was estimated at 54.2% and 32.4% under reporting for stomach cancer in a period of three years (2008 - 2010). MV% and percentage of unknown primary site of the tumor were 68.7%, and 5% respectively. The mortality-to-incidence ratio for men and women was 37.6% and 28.2%, and percentage of cancer in the elderly was 10.9% in 2010 year. The age-specific rate in girls and boys in age groups of 5 - 9 and 10 - 14 years was lower than minimum of the recommended international standards. Conclusions: The results of this study showed data quality of cancer registry is relatively low in terms of the completeness and validity. Cancer registries should pay great attention to the quality of their data. In addition to technical measures in data processing, continuous evaluation of their quality in order to achieve the set goals is essential.","PeriodicalId":73510,"journal":{"name":"Iranian journal of cancer prevention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68182726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Trends in ovarian cancer incidence in Iran 伊朗卵巢癌发病率趋势
Pub Date : 2016-12-07 DOI: 10.17795/IJCP-5452
Y. Moradi, M. Jafari, S. Chaichian, Sorour Khateri, A. Akbarian, Bahram Moazzami, Kamyar Mansori, Y. Mahmodi, Saeed Samie
Background: Cancer is amajorcause of morbidityandmortality,amongwhichovarian cancer has a high incidenceandcase fatality. Gaining insight into the epidemiology and trends of ovarian cancer can be very influential in cancer screening and treatments programming. This study aimed to investigate the trends in the incidence of ovarian cancer in Iran, because this issue has been neglected so far. Methods: This study is a re-analysis of existing data from the cancer data recording system in Iran during the years 2003 to 2009. The incidence rates reported were standardized according to the world health organization (WHO) and the trend in the incidence of this disease was determined by STATA software and the significance of the morbidity trend diagram was also derived via WINPEPI software. Results: The statistics of cancer registry center shows an increasing trend of ovarian cancer from 2003 to 2008, while it decreased from 2008 to 2009. During this period, 6078 cases of ovarian cancer were registered in Iran, increasing from 591 cases in 2003 to 1077 in 2009, which shows an approximately 2-fold increase in the incidence of registered cases. During these seven years, the highest incidence rate was seen in Markazi province with 6.33 per 100,000 persons and the least in Kohkiloye-va-Boyerahmad province with zero incidence. Almost all provinces, except a few, had increasing incidence of ovarian cancer. Conclusions: According to the results of the study, the incidence of ovarian cancer is increasing in Iran, especially in the central and northwestern regions of the country. This increase may be due to changing the patterns of risk factors for this disease, such as changes in lifestyle in the population, which will lead to changes in the incidence of the disease. Hence, due to the increase in incidence of this cancer, it is recommended to implement screening and early detection programs in high risk areas and populations. © 2016, Iranian Journal of Cancer Prevention.
背景:癌症是导致发病率和死亡率的主要原因,其中varian癌具有较高的发病率和病死率。深入了解卵巢癌的流行病学和趋势对癌症筛查和治疗规划具有重要影响。本研究旨在调查伊朗卵巢癌发病率的趋势,因为这个问题迄今为止一直被忽视。方法:本研究是对伊朗2003年至2009年癌症数据记录系统的现有数据进行重新分析。报告的发病率按照世界卫生组织(WHO)标准进行标准化,通过STATA软件确定本病的发病率趋势,并通过WINPEPI软件得出发病率趋势图的意义性。结果:肿瘤登记中心统计数据显示,2003 - 2008年卵巢癌发病率呈上升趋势,2008 - 2009年呈下降趋势。在此期间,伊朗登记了6078例卵巢癌病例,从2003年的591例增加到2009年的1077例,这表明登记病例的发病率增加了大约两倍。在这7年中,马尔卡兹省的发病率最高,为每10万人6.33人,kohkilye -va- boyerahmad省的发病率最低,为零。除少数省份外,几乎所有省份的卵巢癌发病率都在上升。结论:根据研究结果,卵巢癌的发病率在伊朗呈上升趋势,特别是在伊朗中部和西北部地区。这种增加可能是由于这种疾病的风险因素模式的改变,例如人口生活方式的改变,这将导致疾病发病率的变化。因此,由于这种癌症发病率的增加,建议在高风险地区和人群中实施筛查和早期发现计划。©2016,伊朗癌症预防杂志。
{"title":"Trends in ovarian cancer incidence in Iran","authors":"Y. Moradi, M. Jafari, S. Chaichian, Sorour Khateri, A. Akbarian, Bahram Moazzami, Kamyar Mansori, Y. Mahmodi, Saeed Samie","doi":"10.17795/IJCP-5452","DOIUrl":"https://doi.org/10.17795/IJCP-5452","url":null,"abstract":"Background: Cancer is amajorcause of morbidityandmortality,amongwhichovarian cancer has a high incidenceandcase fatality. Gaining insight into the epidemiology and trends of ovarian cancer can be very influential in cancer screening and treatments programming. This study aimed to investigate the trends in the incidence of ovarian cancer in Iran, because this issue has been neglected so far. Methods: This study is a re-analysis of existing data from the cancer data recording system in Iran during the years 2003 to 2009. The incidence rates reported were standardized according to the world health organization (WHO) and the trend in the incidence of this disease was determined by STATA software and the significance of the morbidity trend diagram was also derived via WINPEPI software. Results: The statistics of cancer registry center shows an increasing trend of ovarian cancer from 2003 to 2008, while it decreased from 2008 to 2009. During this period, 6078 cases of ovarian cancer were registered in Iran, increasing from 591 cases in 2003 to 1077 in 2009, which shows an approximately 2-fold increase in the incidence of registered cases. During these seven years, the highest incidence rate was seen in Markazi province with 6.33 per 100,000 persons and the least in Kohkiloye-va-Boyerahmad province with zero incidence. Almost all provinces, except a few, had increasing incidence of ovarian cancer. Conclusions: According to the results of the study, the incidence of ovarian cancer is increasing in Iran, especially in the central and northwestern regions of the country. This increase may be due to changing the patterns of risk factors for this disease, such as changes in lifestyle in the population, which will lead to changes in the incidence of the disease. Hence, due to the increase in incidence of this cancer, it is recommended to implement screening and early detection programs in high risk areas and populations. © 2016, Iranian Journal of Cancer Prevention.","PeriodicalId":73510,"journal":{"name":"Iranian journal of cancer prevention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68181730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Ductal Carcinoma in Situ within a Benign Phyllodes Tumor of Breast: Report of a Case 乳腺良性叶状瘤内导管原位癌1例报告
Pub Date : 2016-12-07 DOI: 10.17795/IJCP-5376
R. Salek, N. S. Sistani, M. Forghani, Mahboobeh Sadeghi Ivari
Introduction: Phyllodes tumor (PT) is not a common phenomenon and its coexistence with ductal carcinoma in situ (DCIS) is extremely rare. A few of these cases have been reported in the literatures. Case Presentation: We report a case of PT that a DCIS tumor has arisen from its epithelial component in a 26 year-old woman. The patient was referred to a surgeon with a palpable mass in her left breast. Ultrasonography failed to distinguish between fibroadenoma and PT. Excisional biopsy was performed for her and after pathologic study, the above - mentioned diagnosis was reported. Histologically stroma showed moderate cellularity with few mitoses. The epithelial component consisted of foci of ductal hyperplasia with comedo necrosis. After consultation with oncologists, simple mastectomy and reconstruction was performed for her. The patient was satisfied with the results. Conclusions: Diagnosis of DCIS within a PT before surgery is impossible and pathologist should confirm it. Different plans for their treatment have had good short term results.
叶状瘤(Phyllodes tumor, PT)并不常见,与导管原位癌(ductal carcinoma in situ, DCIS)共存极为罕见。文献中已经报道了其中的一些病例。病例介绍:我们报告一个26岁女性的DCIS肿瘤起源于其上皮成分。病人因左乳房有明显肿块而被转诊给外科医生。超声检查未能区分纤维腺瘤和PT。对她进行了切除活检,经病理检查后,报告了上述诊断。组织学上基质呈中等细胞性,有丝分裂少。上皮组织由导管增生灶和粉刺样坏死组成。在咨询了肿瘤学家后,为她进行了简单的乳房切除术和重建。病人对结果很满意。结论:术前在PT内诊断DCIS是不可能的,需经病理证实。不同的治疗方案都有很好的短期效果。
{"title":"Ductal Carcinoma in Situ within a Benign Phyllodes Tumor of Breast: Report of a Case","authors":"R. Salek, N. S. Sistani, M. Forghani, Mahboobeh Sadeghi Ivari","doi":"10.17795/IJCP-5376","DOIUrl":"https://doi.org/10.17795/IJCP-5376","url":null,"abstract":"Introduction: Phyllodes tumor (PT) is not a common phenomenon and its coexistence with ductal carcinoma in situ (DCIS) is extremely rare. A few of these cases have been reported in the literatures. Case Presentation: We report a case of PT that a DCIS tumor has arisen from its epithelial component in a 26 year-old woman. The patient was referred to a surgeon with a palpable mass in her left breast. Ultrasonography failed to distinguish between fibroadenoma and PT. Excisional biopsy was performed for her and after pathologic study, the above - mentioned diagnosis was reported. Histologically stroma showed moderate cellularity with few mitoses. The epithelial component consisted of foci of ductal hyperplasia with comedo necrosis. After consultation with oncologists, simple mastectomy and reconstruction was performed for her. The patient was satisfied with the results. Conclusions: Diagnosis of DCIS within a PT before surgery is impossible and pathologist should confirm it. Different plans for their treatment have had good short term results.","PeriodicalId":73510,"journal":{"name":"Iranian journal of cancer prevention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68181845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Environmental Monitoring of Occupational Exposure to Cyclophosphamide Drug in Two Iranian Hospitals 伊朗两家医院职业性环磷酰胺药物暴露环境监测
Pub Date : 2016-12-07 DOI: 10.17795/IJCP-7229
M. Azari, Davod Panahi, M. Akbari, H. Mirzaei, H. Rezvani, R. Zendehdel, Y. Mehrabi, M. Bayatian
Background: Most cytotoxic drugs are unable to discriminate normal cells from cancer cells and they interfere with cell division and could lead to harmful effects such as carcinogenicity, genetic mutation, and teratogenicity. In order to assess dermal occupational exposure to cytotoxic drugs, surface sampling was used to determine the residual drugs on the working surfaces, as well as the effectiveness of the procedures for cleaning the treatment area. Objectives: This study was designed with the aim to investigate the contamination of surfaces and hand skin of the oncology staff with cyclophosphamide drug. Methods: Environmental and personal monitoring were performed by collecting wipe and dermal samples over the span of a month at two different times of handling of cytotoxic drugs or other work like cleaning and patient admission. Samples were taken from exposed oncology staff after administering cyclophosphamide to patient. Results: The method of sampling and analysis of cyclophosphamide over a linear range surface density of 30 - 180 ng/cm2 was validated. Cyclophosphamide was detected on some wipe samples at two hospitals. Results of this study demonstrated that some staff had dermal exposure to cyclophosphamide and it was also revealed that working surfaces were also contaminated with this drug. Conclusions: Health workers with present work practice are at risk with cytotoxic drugs. Therefore, adequate training and control measures are justified.
背景:大多数细胞毒性药物不能区分正常细胞和癌细胞,它们干扰细胞分裂,并可能导致有害的影响,如致癌、基因突变和致畸。为了评估皮肤对细胞毒性药物的职业性暴露,使用表面取样来确定工作表面的残留药物,以及清洁处理区域的程序的有效性。目的:探讨环磷酰胺类药物对肿瘤医护人员表面及手部皮肤的污染情况。方法:在一个月的时间里,在处理细胞毒性药物或其他工作(如清洁和病人入院)的两个不同时间,通过收集擦拭和皮肤样本进行环境和个人监测。对患者施用环磷酰胺后,从暴露的肿瘤学工作人员身上采集样本。结果:在表面密度30 ~ 180 ng/cm2线性范围内对环磷酰胺进行取样分析的方法有效。在两家医院的一些擦拭样本中检测到环磷酰胺。本研究结果表明,一些工作人员皮肤接触到环磷酰胺,工作表面也被该药物污染。结论:目前从事工作的卫生工作者存在细胞毒性药物的风险。因此,适当的培训和控制措施是合理的。
{"title":"Environmental Monitoring of Occupational Exposure to Cyclophosphamide Drug in Two Iranian Hospitals","authors":"M. Azari, Davod Panahi, M. Akbari, H. Mirzaei, H. Rezvani, R. Zendehdel, Y. Mehrabi, M. Bayatian","doi":"10.17795/IJCP-7229","DOIUrl":"https://doi.org/10.17795/IJCP-7229","url":null,"abstract":"Background: Most cytotoxic drugs are unable to discriminate normal cells from cancer cells and they interfere with cell division and could lead to harmful effects such as carcinogenicity, genetic mutation, and teratogenicity. In order to assess dermal occupational exposure to cytotoxic drugs, surface sampling was used to determine the residual drugs on the working surfaces, as well as the effectiveness of the procedures for cleaning the treatment area. Objectives: This study was designed with the aim to investigate the contamination of surfaces and hand skin of the oncology staff with cyclophosphamide drug. Methods: Environmental and personal monitoring were performed by collecting wipe and dermal samples over the span of a month at two different times of handling of cytotoxic drugs or other work like cleaning and patient admission. Samples were taken from exposed oncology staff after administering cyclophosphamide to patient. Results: The method of sampling and analysis of cyclophosphamide over a linear range surface density of 30 - 180 ng/cm2 was validated. Cyclophosphamide was detected on some wipe samples at two hospitals. Results of this study demonstrated that some staff had dermal exposure to cyclophosphamide and it was also revealed that working surfaces were also contaminated with this drug. Conclusions: Health workers with present work practice are at risk with cytotoxic drugs. Therefore, adequate training and control measures are justified.","PeriodicalId":73510,"journal":{"name":"Iranian journal of cancer prevention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68182423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Treatment Compliance and Outcome in Geriatric Patients with Locally Advanced Non-Small Cell Lung Cancer: Experience from India 局部晚期非小细胞肺癌老年患者的治疗依从性和结果:来自印度的经验
Pub Date : 2016-12-07 DOI: 10.17795/IJCP-5481
S. Pathy, Soumyajit Roy, P. Malik, B. Mohanti, V. Raina
Objectives: To evaluate treatment compliance, toxicity and survival in geriatric patients ( ≥ 65 years) with locally advanced non-small cell lung cancer (LA-NSCLC). Methods: Departmental archive was collected for the details of demographics, treatment and outcome in elderly patients with LA-NSCLC (2008 - 2013) (n = 96). Both progression-free survival (PFS) and overall survival (OS) were evaluated using Kaplan-Meier method. Acute and late morbidity were scored using common terminology criteria for adverse events version 4, radiation therapy and oncology group late morbidity scoring system. Results: Overalltreatmentcompletionratewas65%. Theratesof acutegrade ≥ 3hematologicandnon-hematologictoxicitieswere 20% and 17% respectively. Overall rate of late toxicity was 12.5%. The median PFS and OS values were 7.4 months and 10.54 months, respectively. Patients with multiple comorbidities, poor socio-economic background and serum albumin level (< 3.5g/dL) were observed to have poor survival. Survival was lower for non-compliant patients. Conclusions: Curative multi-modality therapy in elderly patients with LA-NSCLC is a challenging task. They are susceptible to poor compliance, treatment-associated toxicities and poor survival. ulation with LA-NSCLC. The study reveals a treatment adherence rate of 65% among geriatric patients ( ≥ 65 years) with locally advanced NSCLC. Poor treatment compliance levelandmulti-ple poor therefore,
目的:评估老年(≥65岁)局部晚期非小细胞肺癌(LA-NSCLC)患者的治疗依从性、毒性和生存率。方法:收集科室档案资料,收集2008 - 2013年LA-NSCLC老年患者(n = 96)的人口学、治疗及转归资料。采用Kaplan-Meier法评估无进展生存期(PFS)和总生存期(OS)。使用不良事件通用术语标准第4版、放射治疗组和肿瘤组晚期发病率评分系统对急性和晚期发病率进行评分。结果:Overalltreatmentcompletionratewas65%。急性≥3级血液学毒性和非血液学毒性分别占20%和17%。晚期毒性总发生率为12.5%。中位PFS和OS值分别为7.4个月和10.54个月。合并多种合并症、社会经济背景差、血清白蛋白水平< 3.5g/dL的患者生存期较差。非依从性患者的生存率较低。结论:老年LA-NSCLC患者的多模式治疗是一项具有挑战性的任务。他们易受治疗依从性差、治疗相关毒性和生存率差的影响。LA-NSCLC。该研究显示,局部晚期NSCLC老年患者(≥65岁)的治疗依从率为65%。治疗依从性水平差,因此多重不良;
{"title":"Treatment Compliance and Outcome in Geriatric Patients with Locally Advanced Non-Small Cell Lung Cancer: Experience from India","authors":"S. Pathy, Soumyajit Roy, P. Malik, B. Mohanti, V. Raina","doi":"10.17795/IJCP-5481","DOIUrl":"https://doi.org/10.17795/IJCP-5481","url":null,"abstract":"Objectives: To evaluate treatment compliance, toxicity and survival in geriatric patients ( ≥ 65 years) with locally advanced non-small cell lung cancer (LA-NSCLC). Methods: Departmental archive was collected for the details of demographics, treatment and outcome in elderly patients with LA-NSCLC (2008 - 2013) (n = 96). Both progression-free survival (PFS) and overall survival (OS) were evaluated using Kaplan-Meier method. Acute and late morbidity were scored using common terminology criteria for adverse events version 4, radiation therapy and oncology group late morbidity scoring system. Results: Overalltreatmentcompletionratewas65%. Theratesof acutegrade ≥ 3hematologicandnon-hematologictoxicitieswere 20% and 17% respectively. Overall rate of late toxicity was 12.5%. The median PFS and OS values were 7.4 months and 10.54 months, respectively. Patients with multiple comorbidities, poor socio-economic background and serum albumin level (< 3.5g/dL) were observed to have poor survival. Survival was lower for non-compliant patients. Conclusions: Curative multi-modality therapy in elderly patients with LA-NSCLC is a challenging task. They are susceptible to poor compliance, treatment-associated toxicities and poor survival. ulation with LA-NSCLC. The study reveals a treatment adherence rate of 65% among geriatric patients ( ≥ 65 years) with locally advanced NSCLC. Poor treatment compliance levelandmulti-ple poor therefore,","PeriodicalId":73510,"journal":{"name":"Iranian journal of cancer prevention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68181738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Fine-Needle Aspirations in Atypia of Unknown Significance/Follicular Lesion Undetermined Significance (AUS/FLUS): Usefulness of Repeated FNA of Thyroid Nodules 意义不明的异型性/意义不明的滤泡性病变(AUS/FLUS)的细针穿刺:甲状腺结节重复FNA的有效性
Pub Date : 2016-12-07 DOI: 10.17795/IJCP-7879
M. Nazem, Behrouz Kaleydari, M. Kolahdouzan, Valiollah Kashi, M. Amini
Background: One of the first steps to determine the thyroid nodules nature is fine needle aspiration. Almost 15% of the nodules are reported as atypia of unknown significance/follicular lesion of unknown significance (AUS/FLUS), with no clear nature of benign or malignant cells. Objectives: This study aimed to evaluate the diagnostic value of repeated FNA in patients with AUS/FLUS undergoing thyroidectomy. Methods: This trial was conducted on 50 patients candidate for thyroid surgery due to both FNA report (AUS/FLUS) and clinical/ ultrasound findings from 2013 - 2014 in a referral surgery centre. First, a new FNA sample was taken from the lesion during surgery and was sent for cytopatholgy. Then, permanent pathology results (as gold standard method of diagnosis) and repeated FNA reports were analyzed and compared. The data were analyzed using SPSS Ver. 17, with P values less than 0.05 being considered significant. Results: The obtained results revealed that repeated FNA had sensitivity of 61.9%, specificity of 100%. It had 0% false positive and 38.1% false negative results. In our study the malignancy rate in repeated FNA was 26%. Also, according to the results, the positive and negative predictive values were 100% and 46.7% respectively, and the accuracy was reported as 71.4%. Conclusions: Repeated FNA for AUS/FLUS has low sensitivity and negative predictive value despite 100% specificity and positive predictive value. Also, the prevalence of “undetermined” reports in repeated FNA for such lesions is high. It is recommended that repeating FNA for AUS/FLUS may have a limited role in decision making for managing patients with this type of thyroid nodules.
背景:确定甲状腺结节性质的第一步是细针穿刺。据报道,近15%的结节为不明意义的异型性/不明意义的滤泡性病变(AUS/FLUS),没有明确的良性或恶性细胞的性质。目的:本研究旨在评价重复FNA在行甲状腺切除术的AUS/流感患者中的诊断价值。方法:本试验纳入了一家转诊外科中心2013 - 2014年因FNA报告(AUS/FLUS)和临床/超声检查结果而拟行甲状腺手术的50例患者。首先,在手术中从病变中提取新的FNA样本并送去细胞病理学检查。然后,将永久性病理结果(作为诊断的金标准方法)与重复FNA报告进行分析和比较。数据采用SPSS Ver. 17进行分析,P值小于0.05为显著性。结果:重复FNA的敏感性为61.9%,特异性为100%。假阳性为0%,假阴性为38.1%。在我们的研究中,重复FNA的恶性率为26%。结果表明,阳性预测值为100%,阴性预测值为46.7%,准确率为71.4%。结论:重复FNA检测AUS/FLUS的特异性为100%,预测值为阳性,但敏感性低,预测值为阴性。此外,重复FNA对此类病变的“不确定”报告的患病率很高。建议对AUS/FLUS进行重复FNA检查可能对此类甲状腺结节患者的治疗决策作用有限。
{"title":"Fine-Needle Aspirations in Atypia of Unknown Significance/Follicular Lesion Undetermined Significance (AUS/FLUS): Usefulness of Repeated FNA of Thyroid Nodules","authors":"M. Nazem, Behrouz Kaleydari, M. Kolahdouzan, Valiollah Kashi, M. Amini","doi":"10.17795/IJCP-7879","DOIUrl":"https://doi.org/10.17795/IJCP-7879","url":null,"abstract":"Background: One of the first steps to determine the thyroid nodules nature is fine needle aspiration. Almost 15% of the nodules are reported as atypia of unknown significance/follicular lesion of unknown significance (AUS/FLUS), with no clear nature of benign or malignant cells. Objectives: This study aimed to evaluate the diagnostic value of repeated FNA in patients with AUS/FLUS undergoing thyroidectomy. Methods: This trial was conducted on 50 patients candidate for thyroid surgery due to both FNA report (AUS/FLUS) and clinical/ ultrasound findings from 2013 - 2014 in a referral surgery centre. First, a new FNA sample was taken from the lesion during surgery and was sent for cytopatholgy. Then, permanent pathology results (as gold standard method of diagnosis) and repeated FNA reports were analyzed and compared. The data were analyzed using SPSS Ver. 17, with P values less than 0.05 being considered significant. Results: The obtained results revealed that repeated FNA had sensitivity of 61.9%, specificity of 100%. It had 0% false positive and 38.1% false negative results. In our study the malignancy rate in repeated FNA was 26%. Also, according to the results, the positive and negative predictive values were 100% and 46.7% respectively, and the accuracy was reported as 71.4%. Conclusions: Repeated FNA for AUS/FLUS has low sensitivity and negative predictive value despite 100% specificity and positive predictive value. Also, the prevalence of “undetermined” reports in repeated FNA for such lesions is high. It is recommended that repeating FNA for AUS/FLUS may have a limited role in decision making for managing patients with this type of thyroid nodules.","PeriodicalId":73510,"journal":{"name":"Iranian journal of cancer prevention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68182488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cancer-Testis Antigens: A Novel Group of Tumor Biomarkers in Ovarian Cancers 癌睾丸抗原:卵巢癌中一组新的肿瘤生物标志物
Pub Date : 2016-12-06 DOI: 10.17795/IJCP-4993
Z. Taherian-Esfahani, A. Abedin-Do, Elahe Nikpayam, Behnoosh Tasharofi, Akram Ghahghaei Nezamabadi, S. Ghafouri-Fard
Context: Ovarian cancer is the most fatal gynecological malignancy with no effective screening strategy for early detection. As mostcasesarebeingdetectedinadvancestages,conventionaltherapiesarenotbeneficialforthemajorityof patients. Cancer-testis antigens (CTAs) are a group of tumor associated antigens with specific expression pattern in cancers which potentiate them for application as cancer biomarkers and targets for immunotherapy. Evidence Acquisition: We performed a computerized search of the MEDLINE/PUBMED databases with key words: ovarian cancer, cancer-testis antigen, biomarker and immunotherapy. Results: Thirty five CTAs have been shown to be expressed in ovarian cancer. At least 13 of them have been shown to elicit immune responses in different studies. The pattern of expression for some of them may facilitate molecular classification of different histo-logicclassesof ovariancancer. Inaddition,someCTAssuchasNY-ESO-1andMAGEhavebeenusedastargetsforimmunotherapeutic approaches with promising results. Conclusions: The expression pattern of CTAs in ovarian cancer and the preliminary results of clinical trials indicate that CTAs can be used as targets for immunotherapy of ovarian cancer patients.
背景:卵巢癌是最致命的妇科恶性肿瘤,没有有效的早期发现筛查策略。由于大多数病例被发现有优势,传统疗法对大多数患者并不有益。癌睾丸抗原(cta)是一类在肿瘤中具有特异性表达模式的肿瘤相关抗原,可作为肿瘤生物标志物和免疫治疗靶点。证据获取:我们对MEDLINE/PUBMED数据库进行计算机检索,关键词:卵巢癌、癌睾丸抗原、生物标志物和免疫治疗。结果:35个cta在卵巢癌中有表达。在不同的研究中,至少有13种被证明能引起免疫反应。其中一些基因的表达模式可能有助于卵巢癌不同组织逻辑类别的分子分类。此外,ny - eso -1和mage已被用作免疫治疗方法的靶点,并取得了令人鼓舞的结果。结论:cta在卵巢癌中的表达模式和临床试验的初步结果表明,cta可以作为卵巢癌患者免疫治疗的靶点。
{"title":"Cancer-Testis Antigens: A Novel Group of Tumor Biomarkers in Ovarian Cancers","authors":"Z. Taherian-Esfahani, A. Abedin-Do, Elahe Nikpayam, Behnoosh Tasharofi, Akram Ghahghaei Nezamabadi, S. Ghafouri-Fard","doi":"10.17795/IJCP-4993","DOIUrl":"https://doi.org/10.17795/IJCP-4993","url":null,"abstract":"Context: Ovarian cancer is the most fatal gynecological malignancy with no effective screening strategy for early detection. As mostcasesarebeingdetectedinadvancestages,conventionaltherapiesarenotbeneficialforthemajorityof patients. Cancer-testis antigens (CTAs) are a group of tumor associated antigens with specific expression pattern in cancers which potentiate them for application as cancer biomarkers and targets for immunotherapy. Evidence Acquisition: We performed a computerized search of the MEDLINE/PUBMED databases with key words: ovarian cancer, cancer-testis antigen, biomarker and immunotherapy. Results: Thirty five CTAs have been shown to be expressed in ovarian cancer. At least 13 of them have been shown to elicit immune responses in different studies. The pattern of expression for some of them may facilitate molecular classification of different histo-logicclassesof ovariancancer. Inaddition,someCTAssuchasNY-ESO-1andMAGEhavebeenusedastargetsforimmunotherapeutic approaches with promising results. Conclusions: The expression pattern of CTAs in ovarian cancer and the preliminary results of clinical trials indicate that CTAs can be used as targets for immunotherapy of ovarian cancer patients.","PeriodicalId":73510,"journal":{"name":"Iranian journal of cancer prevention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68181108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Human Development Index (HDI) in Iran 伊朗人类发展指数(HDI
Pub Date : 2016-10-29 DOI: 10.17795/IJCP-9408
M. Akbari
{"title":"Human Development Index (HDI) in Iran","authors":"M. Akbari","doi":"10.17795/IJCP-9408","DOIUrl":"https://doi.org/10.17795/IJCP-9408","url":null,"abstract":"","PeriodicalId":73510,"journal":{"name":"Iranian journal of cancer prevention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68182902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 54
Potential anticarcinogenic effects of lactic acid bacteria and probiotics in detoxification of process-induced food toxicants 乳酸菌和益生菌在解毒过程中诱发食品毒物的潜在抗癌作用
Pub Date : 2016-10-18 DOI: 10.17795/IJCP-7920
Nasim Khorshidian, M. Y. Asli, H. Hosseini, Mahdi Shadnoush, A. Mortazavian
Context: Nowadays, it has been proved that there is a relation between dietary habits and incidence of different types of cancers. Consumption of processed foods exposes human to a wide range of toxicants such as heterocyclic aromatic amines, polycyclic aromatic hydrocarbons, acrylamide and nitrosamines that have mutagenic and carcinogenic effects on body and especially induce colon cancer. Under such circumstances, search for antimutagenic agents and helpful strategies have gained interest. Evidence Acquisition: We performed a computerized search of Scopus, Pubmed and google scholar databases with keywords: cancer, food toxicants, lactic acid bacteria, and probiotics. Results: Natural dietary compounds like lactic acid bacteria and probiotics can be beneficial in decline of detrimental effects associated with toxicants formed during food processing. It has been stated that binding ability of lactic acid bacteria and probiotics via their cell wall have prominent roles in detoxifying these toxicants. Also, this capability is influenced by various factors. Conclusions: It can be concluded that probiotics can play a vital role in prevention of colon cancer that is induced by food toxicants and their incorporation into food can be helpful in this respect. Keywords: Anticarcinogenic; Cancer; Food Toxicants; Lactic Acid Bacteria; Probiotics
背景:如今,已经证明饮食习惯与不同类型癌症的发病率之间存在联系。食用加工食品会使人体接触到多种有毒物质,如杂环芳香族胺、多环芳香族烃、丙烯酰胺和亚硝胺,这些物质对人体具有诱变和致癌作用,尤其是会诱发结肠癌。在这种情况下,寻找抗诱变剂和有效的策略引起了人们的兴趣。证据获取:我们对Scopus、Pubmed和谷歌学者数据库进行了计算机检索,关键词:癌症、食品毒物、乳酸菌和益生菌。结果:乳酸菌和益生菌等天然膳食化合物有助于减少与食品加工过程中形成的有毒物质相关的有害影响。已有研究表明,乳酸菌和益生菌通过细胞壁的结合能力在解毒中起着重要作用。此外,这种能力还受到各种因素的影响。结论:益生菌在预防食物毒物引起的结肠癌中具有重要作用,在食物中添加益生菌是有益的。关键词:抗癌的;癌症;食品毒物;乳酸菌;益生菌
{"title":"Potential anticarcinogenic effects of lactic acid bacteria and probiotics in detoxification of process-induced food toxicants","authors":"Nasim Khorshidian, M. Y. Asli, H. Hosseini, Mahdi Shadnoush, A. Mortazavian","doi":"10.17795/IJCP-7920","DOIUrl":"https://doi.org/10.17795/IJCP-7920","url":null,"abstract":"Context: Nowadays, it has been proved that there is a relation between dietary habits and incidence of different types of cancers. Consumption of processed foods exposes human to a wide range of toxicants such as heterocyclic aromatic amines, polycyclic aromatic hydrocarbons, acrylamide and nitrosamines that have mutagenic and carcinogenic effects on body and especially induce colon cancer. Under such circumstances, search for antimutagenic agents and helpful strategies have gained interest. \u0000Evidence Acquisition: We performed a computerized search of Scopus, Pubmed and google scholar databases with keywords: cancer, food toxicants, lactic acid bacteria, and probiotics. \u0000Results: Natural dietary compounds like lactic acid bacteria and probiotics can be beneficial in decline of detrimental effects associated with toxicants formed during food processing. It has been stated that binding ability of lactic acid bacteria and probiotics via their cell wall have prominent roles in detoxifying these toxicants. Also, this capability is influenced by various factors. \u0000Conclusions: It can be concluded that probiotics can play a vital role in prevention of colon cancer that is induced by food toxicants and their incorporation into food can be helpful in this respect. \u0000Keywords: Anticarcinogenic; Cancer; Food Toxicants; Lactic Acid Bacteria; Probiotics","PeriodicalId":73510,"journal":{"name":"Iranian journal of cancer prevention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68182577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 33
Hypoxia Response Elements Can Cause the Overexpression of the BAX mRNA Under Hypoxic Condition 缺氧反应元件可引起缺氧条件下BAX mRNA的过表达
Pub Date : 2016-10-05 DOI: 10.17795/IJCP-4554
Ali Ghanbariasad, M. Bandehpour, B. Kazemi
Background: Suicide gene therapy is one of the modern methods of cancer treatment. However, transmission for tumor cells is one of the main challenges to overcome. Hypoxia is a common phenomenon in solid tumors that lead to changes in tumors microenvironment. Hypoxia-responsive element sequences are regulatory sequences that lead to activation of their upstream and downstream genes in hypoxic time. Bax is a strong proapoptotic gene that causes apoptosis in the time of over expression in cells. Objectives: The aim of this study is to use this sequence in order to specify suicide gene therapy by the help of a gene producing Bax protein under control of CMV promoter. Methods: The gene of BAX, BAX3HRE and 3HRE were cloned into interested vectors. In the next step, the function of HRE sequence on over expression of upstream gene under hypoxic condition was evaluated through western blot, MTT assay and real time PCR. Results: The results of this study indicate that cells transected by pcDNA3.1/BAX 3HRE. The rate of apoptosis in them significantly increased in comparison with pcDNA3.1/BAX in hypoxic conditions. Conclusions: Regarding the role of HREs in increasing the expression of its upstream genes, it can be used to specify suicide gene therapy in treatment of solid tumors.
背景:自杀基因治疗是现代癌症治疗方法之一。然而,肿瘤细胞的传播是需要克服的主要挑战之一。缺氧是实体肿瘤的常见现象,导致肿瘤微环境的改变。低氧响应元件序列是在缺氧时间导致其上游和下游基因激活的调控序列。Bax是一种强促凋亡基因,在细胞中过表达时导致细胞凋亡。目的:本研究的目的是利用该序列在CMV启动子控制下产生Bax蛋白的基因帮助下确定自杀基因治疗。方法:将BAX、BAX3HRE和BAX3HRE基因克隆到感兴趣的载体上。下一步,通过western blot、MTT和real - time PCR检测HRE序列在缺氧条件下对上游基因过表达的作用。结果:本研究结果表明,pcDNA3.1/BAX 3HRE对细胞进行了横切。与缺氧条件下的pcDNA3.1/BAX相比,它们的凋亡率明显升高。结论:就HREs增加其上游基因表达的作用而言,可用于指定自杀基因疗法治疗实体瘤。
{"title":"Hypoxia Response Elements Can Cause the Overexpression of the BAX mRNA Under Hypoxic Condition","authors":"Ali Ghanbariasad, M. Bandehpour, B. Kazemi","doi":"10.17795/IJCP-4554","DOIUrl":"https://doi.org/10.17795/IJCP-4554","url":null,"abstract":"Background: Suicide gene therapy is one of the modern methods of cancer treatment. However, transmission for tumor cells is one of the main challenges to overcome. Hypoxia is a common phenomenon in solid tumors that lead to changes in tumors microenvironment. Hypoxia-responsive element sequences are regulatory sequences that lead to activation of their upstream and downstream genes in hypoxic time. Bax is a strong proapoptotic gene that causes apoptosis in the time of over expression in cells. Objectives: The aim of this study is to use this sequence in order to specify suicide gene therapy by the help of a gene producing Bax protein under control of CMV promoter. Methods: The gene of BAX, BAX3HRE and 3HRE were cloned into interested vectors. In the next step, the function of HRE sequence on over expression of upstream gene under hypoxic condition was evaluated through western blot, MTT assay and real time PCR. Results: The results of this study indicate that cells transected by pcDNA3.1/BAX 3HRE. The rate of apoptosis in them significantly increased in comparison with pcDNA3.1/BAX in hypoxic conditions. Conclusions: Regarding the role of HREs in increasing the expression of its upstream genes, it can be used to specify suicide gene therapy in treatment of solid tumors.","PeriodicalId":73510,"journal":{"name":"Iranian journal of cancer prevention","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68181217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Iranian journal of cancer prevention
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1